ArticleBMC cancer2025

Efficacy and safety of first-line chemoimmunotherapy in young patients with extensive-stage small cell lung cancer: a multicenter retrospective study.

Lijuan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.